• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·301111.SZ
Share

Guangdong Lifestrong Pharmacy Co., Ltd. Stocks

CN¥ 22.35Last Updated 13.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

CN¥ 537.19M

CN¥ 22.35
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Guangdong Lifestrong Pharmacy Co., Ltd. is a pharmaceutical company primarily involved in the research, development, manufacturing, and sales of various medical products. Its extensive product range includes different dosage forms such as tablets, pills, injections, mixtures, and granules. The company's therapeutic areas of focus encompass respiratory conditions, pediatric care, gynecology, urinary tract health, and nutritional and general healthcare solutions. This enterprise was established in 1951 and operates out of Shantou, China.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overvalued on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 21:33

SpaceX will become the internet provider for Frontier flights. Why this matters

14.07.2026 20:52

BofA recommended selling Papa John's stock. What raised analysts' concerns?

14.07.2026 20:41

Trump has lifted the requirement for ships to pay a toll to pass through the Strait of Hormuz

14.07.2026 19:14

"Life is unpredictable": Buffett has set a deadline for distributing his shares

14.07.2026 18:30

Revolut Will Participate in Testing the Digital Euro

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026